NCT01290029View on ClinicalTrials.gov

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 25, 2011

Primary Completion Date

September 23, 2015

Study Completion Date

September 23, 2015

Conditions
Chronic Kidney DiseaseHyperparathyroidism, SecondarySecondary Hyperparathyroidism
Interventions
DRUG

Cinacalcet

Single, oral dose of 0.25 mg/kg cinacalcet

Trial Locations (10)

40202

Research Site, Louisville

64108

Research Site, Kansas City

69120

Research Site, Heidelberg

90095

Research Site, Los Angeles

94143

Research Site, San Francisco

BS2 8BJ

Research Site, Bristol

G3 8SJ

Research Site, Glasgow

LS1 3EX

Research Site, Leeds

M13 9WL

Research Site, Manchester

NG7 2UH

Research Site, Nottingham

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY